Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(577)
•••
Comment by Quattro74on Oct 25, 2019 3:01pm
265 Views
Post# 30270796

RE:I hope Theralase creates a lot of epiphanies in the room.

RE:I hope Theralase creates a lot of epiphanies in the room.
Yeah Vestor,

There will be a few there who will realize what this science really means, and they will undoubtedly know a few deep pockets that will find this company interesting.

vestor111 wrote: It is highly likely some very knowledgable people will be in the room and if TLT's science is laid out reasonably as one might expect, it will be hard for just about anyone from any background,  not to reach the realization that this "deadly food for cancer" may indeed be the holy grail the world has sought for hundreds of years.   

Dr McFarland's compound is one of the most elegant solutions that is conceivable to address the scourge of this deadly disease. 

Rutherrin: Deadly food for cancer that is naturally transported around the body, that not only destroys cancers of all stripes upon controlled activation but also stimulates a natural immune response...that can be made into a generic or personalized vaccine - one for virtually every cancer known.   


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities